Healthcare provider profile · identity verified

Brittany C. Lloyd, MD

Family Practice · KINSTON, NC · NPI 1649666892

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	456	122
Amlodipine Besylate	Amlodipine Besylate	341	106
Omeprazole	Omeprazole	248	61
Gabapentin	Gabapentin	235	56
Lisinopril	Lisinopril	235	55
Rosuvastatin Calcium	Rosuvastatin Calcium	229	69
Levothyroxine Sodium	Levothyroxine Sodium	180	41
Pantoprazole Sodium	Pantoprazole Sodium	173	44
Losartan Potassium	Losartan Potassium	166	47
Potassium Chloride	Potassium Chloride	162	36
Metformin Hcl	Metformin Hcl	156	36
Albuterol Sulfate Hfa	Albuterol Sulfate	126	49
Furosemide	Furosemide	124	33
Metoprolol Succinate	Metoprolol Succinate	124	35
Alendronate Sodium	Alendronate Sodium	115	35
Hydrochlorothiazide	Hydrochlorothiazide	107	33
Duloxetine Hcl	Duloxetine Hcl	102	18
Pravastatin Sodium	Pravastatin Sodium	76	20
Allopurinol	Allopurinol	74	16
Fluticasone Propionate	Fluticasone Propionate	73	31
Hydralazine Hcl	Hydralazine Hcl	69	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	26
Famotidine	Famotidine	65	16
Montelukast Sodium	Montelukast Sodium	65	23
Ozempic	Semaglutide	65	19
Meloxicam	Meloxicam	62	19
Clopidogrel	Clopidogrel Bisulfate	61	12
Jardiance	Empagliflozin	60	12
Sertraline Hcl	Sertraline Hcl	60	14
Trazodone Hcl	Trazodone Hcl	55	13
Tamsulosin Hcl	Tamsulosin Hcl	54	17
Metformin Hcl Er	Metformin Hcl	53	19
Carvedilol	Carvedilol	52	17
Glipizide Er	Glipizide	51	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	16
Pregabalin	Pregabalin	51	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	17
Eliquis	Apixaban	48	12
Tramadol Hcl	Tramadol Hcl	48	13
Linzess	Linaclotide	47	12
Metoprolol Tartrate	Metoprolol Tartrate	46	16
Hydroxyzine Hcl	Hydroxyzine Hcl	43	suppressed
Simvastatin	Simvastatin	42	11
Januvia	Sitagliptin Phosphate	40	suppressed
Ezetimibe	Ezetimibe	39	14
Lorazepam	Lorazepam	39	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	36
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	suppressed
Prednisone	Prednisone	36	26
Warfarin Sodium	Warfarin Sodium	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	12
Trulicity	Dulaglutide	32	suppressed
Alprazolam	Alprazolam	29	12
Valacyclovir	Valacyclovir Hcl	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Methylprednisolone	Methylprednisolone	28	26
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Glipizide	Glipizide	27	12
Clonidine Hcl	Clonidine Hcl	26	suppressed
Colchicine	Colchicine	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	13
Rybelsus	Semaglutide	22	suppressed
Fluconazole	Fluconazole	21	18
Ibuprofen	Ibuprofen	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Topiramate	Topiramate	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Nystatin	Nystatin	18	12
Ondansetron Odt	Ondansetron	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Atenolol	Atenolol	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Cefdinir	Cefdinir	16	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Valsartan	Valsartan	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Prolia	Denosumab	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Levetiracetam Er	Levetiracetam	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nyamyc	Nystatin	12	suppressed
Temazepam	Temazepam	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Dofetilide	Dofetilide	11	suppressed
Finasteride	Finasteride	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error